News

Dr Eve Hanks awarded the RCVS Award 2024 from Royal College of Veterinary Surgeons
Equity Gap congratulated their portfolio company owner, Dr Eve Hanks of MI:RNA Diagnostics who recently received the RCVS Impact Award 2024 from the Royal College of Veterinary Surgeons. Eve and MI:RNA Diagnostics have developed a novel

Quickblock utilised by Ukranian Armed Forces to deliver combat medical training
Quickblock, the interlocking flat-packed building system which is made from 100% recycled plastics is being utilised by the Ukranian Armed Forces to deliver combat medical training. Check out the full article on this link

Amiqus hits charity fundraising milestone
Equity Gap are delighted to congratulate the Amiqus team who have hit a charity fundraising milestone in their partnership with the Scottish Refugee Council. Making a commitment in 2023 to raise £100k over three years, leading

ULEMCO close funding round worth £5m+
Equity Gap’s portfolio company, ULEMCO, who develop activities in hydrogen dual fuel, have recently added to their investor base and raised funds in excess of £5m to support their work and accelerate development. Read the full

Shot Scope announce partnership with Troon®
Shot Scope have announced an expanded partnership with Troon® to become the exclusive data partner of its online Game Performance Hub which allows players to obtain valuable data and improve their game throughout the course. For more

MiAlgae profiled in The Scotsman
Portfolio company MiAlgae was recently profiled in The Scotsman discussing its innovative processes for converting distillery waste into valuable omega-3 fish and pet food. It’s great to see coverage like this as MiAlgae continues to grow

Amiqus partners with UKRI AI Centre for Doctoral Training
In a step towards nurturing the future of Artificial Intelligence, portfolio company Amiqus has partnered with The UKRI AI Centre for Doctoral Training in Responsible and Trustworthy in-the-world Natural Language Processing. Hosted by the University of

Enterobiotix complete £27m round to advance clinical trials
Equity Gap congrates portfolio company EnteroBiotix, which has successfully completed a £27m financing round with the support of new and existing investors, including Equity Gap members. The clinical-stage biotechnology company will use the funding to advance